Rchr
J-GLOBAL ID：201801007746018064
Update date: Aug. 27, 2024 Higashi Satoru
ヒガシ サトル | Higashi Satoru
Research field (3)：
Tumor biology
, Pathobiochemistry
, Molecular biology
Research theme for competitive and other funds (2)： - 2022 - 2025 免疫応答におけるcGAS/STING/TBK1経路の新規制御機構の解明
- 2019 - 2022 Analysis of intracellular dynamics of BACE1 and its regulatory mechanism
-
Satoru Higashi, Hiromichi Shirataki. Physicochemical Properties of α-Taxilin as a Putative Tethering Factor. Dokkyo Medical Journal. 2022. 1. 3. 167-175
-
Satoru Higashi, Tomohiko Makiyama, Hiroshi Sakane, Satoru Nogami, Hiromichi Shirataki. Regulation of Hook1-mediated endosomal sorting of clathrin-independent cargo by γ-taxilin. Journal of cell science. 2022. 135. 1
-
Takao Kamai, Satoru Higashi, Satoshi Murakami, Kyoko Arai, Takashi Namatame, Toshiki Kijima, Hideyuki Abe, Tsengelmaa Jamiyan, Kazuyuki Ishida, Hiromichi Shirataki, et al. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma. Cancer science. 2021. 112. 8. 3375-3387
- Yoshiyuki Yamaguchi, Takao Kamai, Satoru Higashi, Satoshi Murakami, Kyoko Arai, Hiromichi Shirataki, Ken-Ichiro Yoshida. Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer. BMC cancer. 2019. 19. 1. 1137-1137
-
Hideo Yuki, Takao Kamai, Satoshi Murakami, Satoru Higashi, Takahiro Narimatsu, Tsunehito Kambara, Hironori Betsunoh, Hideyuki Abe, Kyoko Arai, Hiromichi Shirataki, et al. Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis. Oncotarget. 2018. 9. 47. 28351-28363
ｍore...